Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Clav Regulatory News (JCH)

Share Price Information for Jpmorgan Clav (JCH)

Share Price is delayed by 15 minutes
Get Live Data
926.00    -4.00 (-0.43%)
Bid:
924.00
Ask:
930.00
Spread: 6.00 (0.649%)
Market Cap: £503.84m
JCH Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Clav Share Chart

Directorate Change

22 Jan 2025 15:48

RNS Number : 3399U
JPMorgan Claverhouse IT PLC
22 January 2025
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

 JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

 

 

APPOINTMENT OF DIRECTOR

 

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

Information disclosed in accordance with the UK Listing Rules 6.4.6 R (1) and 6.4.8 R (1)

 

The Board of JPMorgan Claverhouse Investment Trust plc (the 'Company') is pleased to announce the appointment of Mr. Tom Smethers as a Non-Executive Director of the Company with effect from 3rd February 2025.

 

Mr. Smethers is an experienced finance professional, with a strong background in the FMCG, retail, hospitality and aviation sectors. Mr. Smethers has led major transformation projects, handled multiple M&A processes, and has international experience across Europe, the Middle East, and Australia.

Mr. Smethers was previously a Non-Executive Director and Audit Committee Chair of Artemis Alpha Trust plc and is currently a trustee of the charity, Wings for Warriors. He is presently the Chief Financial Officer at Carlsberg Britvic plc and held senior positions at Costa Coffee, TUI Group, Jumeirah Group LLC, and easyJet plc.

 

Mr. Smethers is a Fellow of the Institute of Chartered Accountants of England and Wales.

 

Mr. Smethers does not own any shares of the Company.

 

The Company discloses this information pursuant to the Financial Conduct Authority's UK Listing Rules 6.4.6 R (1) and 6.4.8 R (1). No further information is to be disclosed pursuant to UK Listing Rules 6.4.8 R (2) to 6.4.8 R (6) in respect of Mr. Smethers.

 

 

22nd January 2025

 

 

For further information, please contact:

Anmol Dhillon

JPMorgan Funds Limited, Company Secretary

0800 20 40 20 (or +44 1268 44 44 70)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABUGDBRSDDGUD
Date   Source Headline
27th Aug 202411:58 amRNSNet Asset Value(s)
23rd Aug 202410:41 amRNSNet Asset Value(s)
22nd Aug 202410:22 amRNSNet Asset Value(s)
21st Aug 202410:23 amRNSNet Asset Value(s)
20th Aug 202410:56 amRNSNet Asset Value(s)
19th Aug 202411:48 amRNSGearing Announcement
19th Aug 202411:04 amRNSNet Asset Value(s)
16th Aug 202410:40 amRNSNet Asset Value(s)
15th Aug 202411:12 amRNSNet Asset Value(s)
14th Aug 202411:05 amRNSNet Asset Value(s)
13th Aug 202410:29 amRNSNet Asset Value(s)
12th Aug 20243:21 pmRNSTen Largest Investments
12th Aug 202410:50 amRNSGearing Announcement
12th Aug 202410:32 amRNSNet Asset Value(s)
9th Aug 202411:52 amRNSHalf-year Report
9th Aug 202410:45 amRNSNet Asset Value(s)
8th Aug 202410:29 amRNSNet Asset Value(s)
7th Aug 202410:33 amRNSNet Asset Value(s)
6th Aug 202410:50 amRNSNet Asset Value(s)
5th Aug 202411:56 amRNSGearing Announcement
5th Aug 202411:05 amRNSNet Asset Value(s)
2nd Aug 202411:11 amRNSNet Asset Value(s)
1st Aug 20241:25 pmRNSNet Asset Value(s)
1st Aug 20248:36 amRNSTotal Voting Rights
31st Jul 202410:15 amRNSNet Asset Value(s)
30th Jul 202410:47 amRNSNet Asset Value(s)
29th Jul 202412:12 pmRNSGearing Announcement
29th Jul 202410:53 amRNSNet Asset Value(s)
26th Jul 202410:53 amRNSNet Asset Value(s)
25th Jul 202410:39 amRNSNet Asset Value(s)
24th Jul 202410:55 amRNSNet Asset Value(s)
23rd Jul 202410:48 amRNSNet Asset Value(s)
22nd Jul 202412:37 pmRNSGearing Announcement
22nd Jul 202411:15 amRNSNet Asset Value(s)
19th Jul 20241:03 pmRNSNet Asset Value(s)
18th Jul 202410:26 amRNSNet Asset Value(s)
17th Jul 202410:50 amRNSNet Asset Value(s)
16th Jul 202410:39 amRNSNet Asset Value(s)
16th Jul 20248:55 amRNSDividend Declaration
15th Jul 202411:37 amRNSGearing Announcement
15th Jul 202410:49 amRNSNet Asset Value(s)
12th Jul 20243:24 pmRNSNet Asset Value(s)
11th Jul 202411:05 amRNSNet Asset Value(s)
10th Jul 202411:13 amRNSNet Asset Value(s)
9th Jul 20244:03 pmRNSTen Largest Investments
9th Jul 202410:59 amRNSNet Asset Value(s)
8th Jul 202412:37 pmRNSGearing Announcement
8th Jul 202411:11 amRNSNet Asset Value(s)
8th Jul 202410:30 amRNSShare Registrar change
5th Jul 202411:01 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.